Literature DB >> 7152734

Taurine for treatment of congestive heart failure.

J Azuma, H Hasegawa, A Sawamura, N Awata, H Harada, K Ogura, S Kishimoto.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7152734     DOI： 10.1016/0167-5273(82)90052-3

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN： 0167-5273            Impact factor:   4.164


× No keyword cloud information.
  3 in total

1.  Non-targeted metabolomics analysis of cardiac Muscle Ring Finger-1 (MuRF1), MuRF2, and MuRF3 in vivo reveals novel and redundant metabolic changes.

Authors:  Ranjan Banerjee; Jun He; Carolyn Spaniel; Megan T Quintana; Zhongjing Wang; James Bain; Christopher B Newgard; Michael J Muehlbauer; Monte S Willis
Journal:  Metabolomics       Date:  2014-07-14       Impact factor: 4.290

2.  Effect of taurine administration on symptoms, severity, or clinical outcome of dilated cardiomyopathy and heart failure in humans: a systematic review.

Authors:  Kathryn A McGurk; Melpomeni Kasapi; James S Ware
Journal:  Wellcome Open Res       Date:  2022-07-07

3.  The potential health benefits of taurine in cardiovascular disease.

Authors:  Yan-Jun Xu; Amarjit S Arneja; Paramjit S Tappia; Naranjan S Dhalla
Journal:  Exp Clin Cardiol       Date:  2008
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.